UK Extends Device, Drug Accelerated Access Review Until April 2016
This article was originally published in Clinica
Executive Summary
A UK government project that is exploring how to support the faster development of, and access to, new drugs and medical devices for patients under the National Health Service will now be finalized in April 2016, rather than at the end of this year as was originally intended. An interim report on the accelerated access review (AAR) project, which is looking at new product development pathways among other things, will be published in October as planned.
You may also be interested in...
UK Accelerated Access Proposals Due Out Soon
One aim of the soon-to-be-published proposals is to make the health environment in the UK more innovation-friendly, in particular for medtech and digital health products. The final report on the government’s Accelerated Access Review should be out by the end of the month.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.